Approximately 10% of the time, we will pick up additional cancers in the same or opposite breast with BSGI
Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as dark spots on the BSGI
image - helping doctors to make more informed decisions about the presence or absence of cancer in high-risk patients or for those who present with inconclusive mammograms.
Breast imaging centers across the country and around the world are using BSGI
to pave the way to effective diagnosis of breast cancer.
Previous studies using BSGI
have shown that the technique improves cancer detection in high-risk women and can detect the earliest breast cancers, even those as small as 1 mm, said Dr.
study takes about 40 minutes with the woman seated in a chair and uses technetium 99-sestamibi, a radiotracer that has been used for more than 15 years in cardiac stress testing.
is an emerging molecular imaging technology using a high-resolution gamma camera that allows for imaging with very mild compression of the breast along with an injection of a low-dose nuclear material called a radiotracer, which is absorbed by the cells.
is ideal for patients with mammograms that are difficult to interpret due to a variety of factors, such as: dense breast tissue, suspicious areas on a mammogram, lumps that can be felt but not seen with mammography or ultrasound, implants and breast augmentation, scarring from previous surgeries and for women with a strong positive family history of breast cancer.
One system blazing a trail in BSGI
is the Dilon 6800, a high-resolution, small field-of-view gamma camera.
measures differences at the cellular level and is not affected by tissue density.
To find out more about BSGI
or the Dilon 6800 Gamma Camera please visit http://www.
A number of studies have compared breast MRI to nuclear medicine techniques, such as BSGI
with the Dilon 6800 (BSGI
) is a molecular breast imaging technique that has proven to be an effective tool in the early detection of breast cancer and in the differentiation of malignant and benign tumors.